Source recordFED

Arch Biopartners Inc.

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2023· $4,000,000· BN 101328227· ON

Description

The project targets the prevention of acute organ inflammation injury in the lungs and kidneys of patients who have moderate to severe COVID-19 and other diseases. LSALT peptide is a novel drug candidate and selective dipeptidase-1 inhibito…

Amendment chain · 2 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $4,000,000 at start, $4,000,000 after amendment #1 (+$0).

$4,000,000$0Original · 2022-11-01 (start date) · total $4,000,000Amendment 1 · 2024-01-29 · total $4,000,000
  • #02022-11-01$4,000,000
  • #12024-01-29$4,000,000
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2022-11-01(start date)$4,000,000—The project targets the prevention of acute organ inflammation injury in the lungs and kidneys of patients who…
#1 amendment2024-01-29$4,000,000+$0The project targets the prevention of acute organ inflammation injury in the lungs and kidneys of patients who…

Related records · 7

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 101328227)

RefDepartment · programCurrent valueFY
033-2020-2021-Q3-513415Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada · SIF Stream 1- R&D$5,407,235FY2021
172-2018-2019-Q4-919337National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Contributions to Firms$200,000FY2019

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2022-2023-Q4-1003639 · retrieved 2026-11-16.